Medical studies link eyelid deposits and blood pressure to heart and brain health

Recent medical studies have identified key external and physiological indicators for cardiovascular and neurological risks. Researchers at Stanford University analyzed data from nearly 36,000 individuals, focusing on xanthelasma—yellowish deposits on the eyelids. The study, published in the journal Atherosclerosis, suggests these deposits may serve as visible markers for increased risks of heart attack and stroke, as they are often linked to lipid metabolism issues and arterial plaque formation.

In a separate study involving data from the SPRINT clinical trial, researchers from Massachusetts General Hospital and UT Health San Antonio utilized MRI imaging to examine the impact of blood pressure management. By analyzing over 9,300 adults aged 50 and older, the study found that more intensive blood pressure control (targeting a systolic limit of 120 mmHg compared to 140 mmHg) significantly slowed the progression of cerebral small vessel disease. Specifically, the group with stricter blood pressure targets saw a 16.9 percent reduction in the progression of brain lesions over a four-year period.